Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
175
-
Total 13F shares, excl. options
-
81.3M
-
Shares change
-
+2.07M
-
Total reported value, excl. options
-
$1.71B
-
Value change
-
+$62.5M
-
Put/Call ratio
-
0
-
Number of buys
-
106
-
Number of sells
-
-66
-
Price
-
$21.05
Significant Holders of Evolent Health, Inc. - Class A Common Stock (EVH) as of Q2 2018
204 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock as of Q2 2018.
Evolent Health, Inc. - Class A Common Stock (EVH) has 175 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 81.3M shares
of 112M outstanding shares and own 72.87% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (7.35M shares), JPMORGAN CHASE & CO (6.98M shares), Bank of New York Mellon Corp (5.58M shares), VANGUARD GROUP INC (5.27M shares), BlackRock Inc. (4.36M shares), RIVERBRIDGE PARTNERS LLC (3.54M shares), MILLENNIUM MANAGEMENT LLC (3.09M shares), DIMENSIONAL FUND ADVISORS LP (2.82M shares), EAGLE ASSET MANAGEMENT INC (2.57M shares), and BLAIR WILLIAM & CO/IL (2.18M shares).
This table shows the top 175 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.